These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17084858)

  • 1. Identification and characterization of single chain anti-cocaine catalytic antibodies.
    McKenzie KM; Mee JM; Rogers CJ; Hixon MS; Kaufmann GF; Janda KD
    J Mol Biol; 2007 Jan; 365(3):722-31. PubMed ID: 17084858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site-directed mutagenesis of active site contact residues in a hydrolytic abzyme: evidence for an essential histidine involved in transition state stabilization.
    Miyashita H; Hara T; Tanimura R; Fukuyama S; Cagnon C; Kohara A; Fujii I
    J Mol Biol; 1997 Apr; 267(5):1247-57. PubMed ID: 9150409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystallographic and biochemical analysis of cocaine-degrading antibody 15A10.
    Larsen NA; de Prada P; Deng SX; Mittal A; Braskett M; Zhu X; Wilson IA; Landry DW
    Biochemistry; 2004 Jun; 43(25):8067-76. PubMed ID: 15209502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catalytic antibodies that hydrolyze (-)-cocaine obtained by a high-throughput procedure.
    Cashman JR; Berkman CE; Underiner GE
    J Pharmacol Exp Ther; 2000 Jun; 293(3):952-61. PubMed ID: 10869397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substrate-assisted antibody catalysis.
    Deng S; Bharat N; de Prada P; Landry DW
    Org Biomol Chem; 2004 Feb; 2(3):288-90. PubMed ID: 14747854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for amide hydrolysis catalyzed by the 43C9 antibody.
    Thayer MM; Olender EH; Arvai AS; Koike CK; Canestrelli IL; Stewart JD; Benkovic SJ; Getzoff ED; Roberts VA
    J Mol Biol; 1999 Aug; 291(2):329-45. PubMed ID: 10438624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmenting the efficacy of anti-cocaine catalytic antibodies through chimeric hapten design and combinatorial vaccination.
    Wenthur CJ; Cai X; Ellis BA; Janda KD
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3666-3668. PubMed ID: 28709828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of humanized anti-DNA hydrolyzing catalytic antibodies by complementarity determining region grafting.
    Kim DS; Lee SH; Kim JS; Lee SC; Kwon MH; Kim YS
    Biochem Biophys Res Commun; 2009 Feb; 379(2):314-8. PubMed ID: 19103171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cocaine catalytic antibodies: the primary importance of linker effects.
    Matsushita M; Hoffman TZ; Ashley JA; Zhou B; Wirsching P; Janda KD
    Bioorg Med Chem Lett; 2001 Jan; 11(2):87-90. PubMed ID: 11206477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of functionally important residues in the pyridoxal-5'-phosphate-dependent catalytic antibody 15A9.
    Mouratou B; Stetefeld J
    Biochemistry; 2004 Jun; 43(21):6612-9. PubMed ID: 15157094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of hapten binding and catalytic determinants in a family of catalytic antibodies.
    Ulrich HD; Schultz PG
    J Mol Biol; 1998 Jan; 275(1):95-111. PubMed ID: 9451442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling the catalysis of anti-cocaine catalytic antibody: competing reaction pathways and free energy barriers.
    Pan Y; Gao D; Zhan CG
    J Am Chem Soc; 2008 Apr; 130(15):5140-9. PubMed ID: 18341277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-catalyzed degradation of cocaine.
    Landry DW; Zhao K; Yang GX; Glickman M; Georgiadis TM
    Science; 1993 Mar; 259(5103):1899-901. PubMed ID: 8456315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing the importance of second sphere residues in an esterolytic antibody by phage display.
    Arkin MR; Wells JA
    J Mol Biol; 1998 Dec; 284(4):1083-94. PubMed ID: 9837728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-directed mutagenesis of proteolytic antibody light chain.
    Gao QS; Sun M; Rees AR; Paul S
    J Mol Biol; 1995 Nov; 253(5):658-64. PubMed ID: 7473741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticocaine catalytic antibodies.
    Deng SX; de Prada P; Landry DW
    J Immunol Methods; 2002 Nov; 269(1-2):299-310. PubMed ID: 12379369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catalytic antibody model and mutagenesis implicate arginine in transition-state stabilization.
    Roberts VA; Stewart J; Benkovic SJ; Getzoff ED
    J Mol Biol; 1994 Jan; 235(3):1098-116. PubMed ID: 8289310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for antibody catalysis of a disfavored ring closure reaction.
    Gruber K; Zhou B; Houk KN; Lerner RA; Shevlin CG; Wilson IA
    Biochemistry; 1999 Jun; 38(22):7062-74. PubMed ID: 10353817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Directed evolution governed by controlling the molecular recognition between an abzyme and its haptenic transition-state analog.
    Takahashi-Ando N; Kakinuma H; Fujii I; Nishi Y
    J Immunol Methods; 2004 Nov; 294(1-2):1-14. PubMed ID: 15604011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational and inhibitory analysis of a catalytic antibody. Implication for drug discovery.
    Phichith D; Bun S; Padiolleau-Lefèvre S; Banh S; Thomas D; Friboulet A; Avalle B
    Mol Immunol; 2009 Dec; 47(2-3):348-56. PubMed ID: 19828199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.